Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
Published on
Nov 21, 2019
Pneumococcal conjugate vaccine use in children has led to sharp declines in pneumococcal disease among adults and children.